Skip to content
MMMERTERTERT

Drawing based on the label description. No photo yet.

“Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate Tablets are available containing 200 mg of emtricitabine, 27.5 mg of rilpivirine hydrochloride equivalent to 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate equivalent to 245 mg of tenofovir disoproxil. The 200 mg/25 mg/300 mg tablets are yellow, film-coated, capsule shaped, unscored tablets debossed with M on one…”

M ERT pill

Pill with imprint M ERT is yellow, capsule, 19 mm and has been identified as Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg. It is used for HIV. It is supplied by Mylan Pharmaceuticals Inc.

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg

Imprint
M ERT
Strength
Emtricitabine 200 mg / Rilpivirine 25 mg / Tenofovir Disoproxil Fumarate 300 mg
Used for
HIV
Color
Yellow
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Mylan Pharmaceuticals Inc
Drug class
HIV medicine
NDC
0378-5440, 0378-5440-93, 0378-5440-77

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Emtricitabine and Rilpivirine and Tenofovir Disoproxil pills and guides

What is Emtricitabine and Rilpivirine and Tenofovir Disoproxil used for?

Emtricitabine and Rilpivirine and Tenofovir Disoproxil is used for HIV.

Medicine type
HIV medicine
Official uses from the US prescribing label

Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg:

  • as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy or
  • to replace a stable antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no treatment failure and no known substitutions associated with resistance to the individual components of emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets.

Limitations of Use:

  • More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥ 50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.

From the FDA-approved label on DailyMed (published May 30, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows M and the other side shows ERT.
  • It is yellow, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Emtricitabine, Rilpivirine Hydrochloride, Tenofovir Disoproxil Fumarate

Inactive: Starch, Corn, Croscarmellose Sodium, Hypromellose 2910 (15000 Mpa.s), Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose 101, Microcrystalline Cellulose 112, Povidone K30, Ferric Oxide Red, Talc, Titanium Dioxide, Triacetin, Ferric Oxide Yellow

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Emtricitabine and Rilpivirine and Tenofovir Disoproxil pills